Authors


MONIQUE R. BIDELL, PHARMD, BCPS

Latest:

The Early Bird Gets to Stay Home: Early OPAT Follow-Up Reduces 30-Day Readmissions

Readmission rates for patients receiving OPAT are reported to be as high as 20%, mostly due to catheter-related problems, adverse drug reactions, or worsening of the primary infection.


P. BRANDON BOOKSTAVER, PHARMD*

Latest:

Get Off the SOFA! Introducing the Quick Pitt Bacteremia Score

The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.


JOHN CHAN, MD

Latest:

The Case of Late Aspergillus Fumigatus Infection of Implantable Cardioverter Defibrillator Leads

Quick action was needed against this very rare cause of fungal endocarditis.


Jason J. Schafer, PharmD, MPH, BCPS AQ-ID, AAHIVP

Latest:

The Power of PrEP

The results of a new study demonstrate that PrEP can reduce new infections within a population even when the risk of HIV remains high and other proven treatment and prevention strategies are optimized.


Bruce M. Jones, PharmD, BCPS

Latest:

Conversations Around Discharge

In the last segment of the series, Jones offered his insights for when he considers discharging patients.


Shawn MacVane, PharmD

Latest:

Fluoroquinolone Antibiotics: More Recommendations for Prudent Use

Despite concerning findings and warnings, fluoroquinolones have remained one of the world’s most commonly prescribed antibiotic classes, with the United States accounting for more than 32 million prescriptions in 2015 alone.


Leah M. Johnson, PhD

Latest:

Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis

Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.


Maricelle O. Monteagudo-Chu, PharmD, BCPS AQ-ID

Latest:

Early Antibiotic Therapy Does Not Improve Mortality in Patients with CAUTI

Catheter-associated urinary tract infections (CAUTIs) account for about 40% of all nosocomial infections in hospitals and nursing homes.


Jane Abernathy, MD Candidate

Latest:

An Unusual Case of Testicular Swelling in a Patient With HIV

Being immunocompromised increases risk of rare Mycobacterium tuberculosis epididymo-orchitis.


Gabriel Sandkovsky, MD

Latest:

Pulmonary Coinfection With C neoformans and C immitis: A Novel Fungal Cohabitation

A patient presented with a history of uncontrolled HIV and a history of polysubstance use.


Lauren A. Igneri, PharmD, BCPS, BCCCP

Latest:

More Than Surviving Sepsis: Everything Old Is New Again

Investigators are dusting off angiotensin II and ascorbic acid for renewed use in treating sepis and septic shock.


JOHN MOHR, PHARMD

Latest:

Implications of the 21st Century Cures Act on Antibiotic Drug Development

Experts weigh in on what Congress is doing to tackle the threat of antibiotic resistance.


ANDREW LEE, MD

Latest:

Cryptosporidium: A Potentially Fatal Cause of Diarrhea in a Heart Transplant Recipient

Expanding the differential for diarrhea beyond Clostridium difficile.


KRISTINE LA, PHARMD CANDIDATE 2018

Latest:

Exciting New Hepatitis C Therapies Approved at the End of 2017

Treatment-experienced patients still have some good options.



MONICA V. MAHONEY, PHARMD, BCPS AQ-ID, BCIDP*

Latest:

Regdanvimab—A New Attack of the (Mono)Clones

A review of the neutralizing antibody that was studied in a phase 2/3 trial in outpatients with mild to moderate infections of COVID-19.



Samara Rosenfeld

Latest:

Obesity Medicine Doctor Turns COVID-19 Infection into Learning Experience

The story of an early-infected US physician who launched a non-profit, participated in trials, and guided her peers after overcoming infection.


Sarah E. Perez, PharmD

Latest:

Antiretroviral Stewardship: The Time is Now

In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.


Kari Oakes, PA-C

Latest:

Tenofovir Plus Interferon Improves Antigen Clearance in Chronic Hepatitis B

Treatment with a combination of tenofovir and pegylated interferon yielded higher rates of hepatitis B surface antigen (HBsAg) loss than when either drug was used singly. Further, with longer therapy duration improved results.


Lorraine L. Janeczko, MPH

Latest:

Ocular Syphilis and Cytomegalovirus Retinitis Have Different Immunologic Profiles

Researchers have found that individuals with cytomegalovirus retinitis have a more advanced HIV infection than individuals with ocular syphilis.


Clarence D. Moore, PharmD, BCPS

Latest:

Decongestants and Hypertension: Dangerous Together

Pharmacists can play an important role in managing the use of these medications in patients, particularly those with high blood pressure.


NICOLE COFFIN, MA

Latest:

Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest Report

A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.


Davey James

Latest:

Gene Therapy Shows Promise in Neutralizing HIV

Researchers safely infuse engineered immune cells in groundbreaking gene therapy study.


Conan MacDougall, PharmD, MAS

Latest:

Intraseasonal Influenza Vaccine Effectiveness Waning: Threading the Needle for Immunity

Evidence is accumulating that influenza vaccination protection wanes over the course of a single influenza season, with significant implications for public health.


Samar Mahmoud, MS

Latest:

Gardnerella Bacteremia Reported in HIV-Positive Male

Investigators from the University of California San Diego Medical School report on the first case of Gardnerella bacteremia in an HIV-positive male following the placement of a urinary catheter.


Noel Abastillas

Latest:

Letters to Doctors Help Fight Over-Prescription of Antibiotics

A new trial conducted in England has discovered a cost-effective way to reduce the overprescribing of antibiotics by general practitioners (GPs).



KRUTIKA KUPPALLI, MD

Latest:

What the 2018 DRC Ebola Epidemic Taught Us About Outbreak Response and Experimental Countermeasures

How has treating infections changed with the availability of experimental vaccines and therapeutics, and how can we apply this to COVID-19 today?


© 2024 MJH Life Sciences

All rights reserved.